Ausgangs-Basisraten
Was ist normal — PI-Quote, Verletzungsquote, Nichtigerklärungsquote, Vergleichsquote. Ehrliche Nenner über Antragstyp.
Erfolgsquote des Patentinhabers
Anteil der Sachentscheidungen, in denen der Patentinhaber obsiegt — Verletzungsklagen mit festgestellter Verletzung, Nichtigkeitsklagen mit bestätigtem Patent. Vergleiche, Klagerücknahmen und rein prozessuale Ausgänge sind aus dem Nenner ausgeschlossen.
Keine Sachentscheidungen im aktuellen Umfang.
PI-Erteilungsquote
0%
0 granted · 1 denied · 2 total decisions
PI-Erteilungsquote (konservativ)
0%
Granted / total PI decisions (incl. interim, withdrawn)
Verletzungsquote
—
Nichtigerklärungsquote
—
Vergleichs-/Rücknahmequote
Settled / withdrawn / dismissed as a share of all non-pending outcomes.
62% 18 / 29
Vergleichszeitpunkt
Wann verglichene oder zurückgenommene Fälle tatsächlich endeten — relativ zu prozessualen Meilensteinen.
Nach Technologiesektor
Top-Sektoren nach Fallzahl (mit Filterbereich).
Nach Fallkategorie
Wie sich Ausgangsraten über die sechs L2-Buckets unterscheiden.
- Berufungen133
Nach Kammer
PI-Erteilungsquote · Verletzungsquote · Nichtigerklärungsquote pro Kammer (im Umfang).
- Court of Appeal133 fällePI-Erteilungsquote: 0%Verletzungsquote: —Nichtigerklärungsquote: —
Aktuelle Entscheidungen
Neueste Entscheidungen im Umfang.
- 2026-03-25UPC_CoA_528/2024Court of AppealZurückgenommenSanofi and Regeneron withdrew their application for rehearing (R.245 RoP) concerning the Court of Appeal's decision of 25 November 2025 (UPC_CoA_528/2024 and UPC_CoA_529/2024) which had rejected the revocation of EP 3 666 797 and set aside the Central Division Munich's first-instance decision. The application for withdrawal was permitted. The decision covers both UPC_CoA_528/2024 and UPC_CoA_529/2024. Court fees were to be reimbursed accordingly.
- 2026-03-24UPC_CoA_935/2025Court of AppealNur prozessualCourt of Appeal dismissed the application for suspensive effect of an appeal against a default judgment of The Hague Local Division. The Court held that an application for suspensive effect must set out all reasons, facts, evidence and arguments at once; a second application is inadmissible unless new submissions could not reasonably have been made earlier.
- 2026-03-16UPC_CoA_904/2025Court of AppealNur prozessualThe Court of Appeal (Panel 1a) dismissed VIVO's appeal against the Paris Local Division's order deferring the decision on the admissibility of claim A.II of the Statement of Claim to the main proceedings. The CoA confirmed that the panel (not only the judge-rapporteur) was competent to make the deferral decision, and that the Paris LD did not exceed its margin of discretion. The appeal also concerned UPC_CoA_905/2025 (EP 3 852 468).
- 2026-03-06UPC_CoA_813/2025Court of AppealPI erteiltThe Court of Appeal extended the provisional measures (preliminary injunction) granted against Dreame International, Teqphone GmbH, and Dreame Technology AB to cover Dyson's 'New Dreame Products' and 'Newest Dreame Products' (EP 3 119 235, vacuum cleaner patent). The Court held that: (1) a structural element in a claim must be interpreted considering both its function and physical configuration; (2) the fact that an infringer has previously committed only certain infringing acts does not restrict an injunction to those specific acts – the existence of past infringement establishes a risk of all acts of use; (3) the date for R. 213.1 RoP compliance was set at 31 calendar days after service.
- 2026-03-06UPC_CoA_813/2025Court of AppealNur prozessualCourt of Appeal referred a question to the CJEU for a preliminary ruling on whether an 'authorised representative' under EU product safety regulations (Regulations 2023/988 and 2019/1020) can be enjoined as an 'intermediary' for patent infringement purposes under Art. 9(1)(a) of Directive 2004/48. The case arises from Dyson's appeal against Hamburg Local Division's refusal to grant provisional measures against Eurep GmbH, the EU authorised representative of Dreame International.
- 2026-03-04UPC_CoA_678/2025Court of AppealNur prozessualThe Court of Appeal (judge-rapporteur Emmanuel Gougé) granted Hurom Co., Ltd.'s application for further exchanges of written pleadings (R. 36 RoP) in the appeal against the Paris Local Division's decision of 23 May 2025 dismissing Hurom's infringement claims and revoking several claims of EP 3 155 936. The CoA allowed further pleadings because Hurom had introduced two new auxiliary requests on appeal (not filed at first instance) and NUC had responded with new prior art documents (D5, D6) and invalidity arguments that Hurom had not yet had an opportunity to address. The principles of due process and the right to be heard justified the further exchange.
- 2026-03-03UPC_CoA_887/2025Court of AppealZurückgenommenThe Court of Appeal permitted Washtower's withdrawal of its application for provisional measures under R. 265 RoP and declared the proceedings closed. Washtower agreed to bear the costs of both first and second instance of the provisional measures proceedings. The Court also determined the value in dispute at 66% of the value of a permanent injunction, in accordance with the Court of Appeal's guidelines on cost ceilings for provisional measure proceedings not followed by a merits action.
- 2026-02-18UPC_CoA_528/2024Court of AppealAbgewiesenThe Court of Appeal (Panel with Klaus Grabinski, Nathalie Sabotier, Peter Blok) rejected Sanofi and Regeneron's application for suspensive effect concerning the Court of Appeal's own decision of 25 November 2025 which had rejected the requests for revocation of EP 3 666 797. Sanofi and Regeneron sought suspensive effect as part of a petition for rehearing (R. 220.4 RoP). The court found no basis to suspend a revocation-rejection decision (as this had no practical effect on the patent's validity status), and rejected the claim that the CoA's reasoning on claim interpretation and inventive step was based on issues not argued by the parties.